期刊
RHEUMATOLOGY
卷 54, 期 5, 页码 768-775出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keu487
关键词
regulatory T cells; rheumatoid arthritis; biologic therapy; anti-TNF therapy
类别
资金
- Versus Arthritis [20131] Funding Source: researchfish
- Arthritis Research UK [20131] Funding Source: Medline
- Versus Arthritis [20131] Funding Source: Medline
Regulatory T cells (Treg) are functionally defective in patients with RA. Restoring their function may not only control inflammation but also restore tolerance in these patients. Biologic therapies have been tremendously successful in treating RA. Here we review numerous reports suggesting that these immunomodulatory therapies have an impact on Treg and that this may contribute to their beneficial effects. Better understanding of their mode of action may not only lead to improvements in therapies and sustained remission but also enable the development of biomarkers of response, which would be the first steps towards personalized medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据